Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The oral soft tissues, acquired pellicle, and dental biofilm matrix represent the complex biological landscape of the oral cavity where dental diseases originate and therapeutic agents act. The acquired pellicle is a thin, protective film of salivary proteins, such as mucins and proline-rich proteins, that forms on tooth enamel and mediates the initial attachment of bacteria (Siqueira et al., 2012, Journal of Dental Research). The dental biofilm matrix, or extracellular polymeric substance (EPS), is a self-produced scaffold of polysaccharides and DNA that protects microbial communities from host defenses and limits the penetration of antimicrobial drugs (Flemming & Wingender, 2010, Nature Reviews Microbiology). Oral soft tissues, including the gingiva and mucosa, serve as a physical barrier and the site of inflammatory responses to pathogenic biofilms (Pihlstrom et al., 2005, The Lancet). Therapeutic strategies often involve the use of mouthwashes or dentifrices containing agents like chlorhexidine, which binds to these surfaces to provide long-lasting antimicrobial activity, a property known as substantivity (Jones, 1997, Periodontology 2000). Furthermore, the interaction between these components determines the efficacy of oral hygiene products, as the matrix can act as a reservoir for active ingredients or a barrier to their diffusion. Managing this environment is essential for preventing and treating prevalent conditions such as dental caries, gingivitis, and periodontitis (Marsh, 2004, BMC Oral Health).
Biofilm disruption, inhibition of bacterial adhesion, surface adsorption and substantivity, antimicrobial activity, and enamel remineralization support.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oral soft tissues, acquired pellicle, and dental biofilm matrix.